All HEI'sAthlone Institute of TechnologyCork Institute of TechnologyDublin City UniversityDublin Institute of TechnologyMaynooth UniversityNational University of Ireland, GalwayRoyal College of SurgeonsTeagascTrinity College DublinUniversity College CorkUniversity College DublinUniversity of LimerickWaterford Institute of Technology All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsDetection of Cause of Pink Discolouration Effect in Cheeses - Licensing Opportunity from Teagasc - October 2015Teagasc is seeking partners within the diagnostics industry to exploit a novel qPCR-based test for supply of assay/kit for detection of the bacterial cause of pinking discolouration defect, to the dairy and cheese indust... pdf 36.1KBRapid detection of toxin-encoding Bacillus Cereus - Licensing Opportunity from Teagasc - October 2015Teagasc is seeking partners within the diagnostics industry to exploit a novel qPCR-based test capable of rapid, simultaneous detection of all Bacillus cereus toxin encoding genes (“CereusToxTest”), of benefit to the foo... pdf 39.6KBLithCTx - Combination drug therapy to prevent esophageal and lung cancers and cancer recurrence - Licensing Opportunity from University College Cork - September 2015A combination drug treatment comprising a chemotherapeutic drug and an autophagy inducing drug results in not only inhibition in the progression of cancer but also prevents the recurrence of cancer which may occur follow... pdf 196.9KBMirStent- cardiac repair therapy following heart attack - Licensing Opportunity from University College Cork - September 2015After suffering a heart attack (i.e. STEMI type), a single dose IGF-1 therapy is effective in decreasing the size of the infarct (dead heart tissue) by at least 60%. Considering extensive use of stents in coronary angiop... pdf 308.9KBIL‐36 Proteolytic Processing Inhibitors - A Enzyme Blocking PolypeptideThe development of a new and novel polypeptide entity that is capable of blocking the enzymes that promote inflammation of the skin such as psoriasis. pdf 341.7KB First 123456789101112131415161718192021 Last Print Bookmark Top